Comparative Pharmacology
Head-to-head clinical analysis: POTASSIUM CHLORIDE 0 22 IN DEXTROSE 5 IN PLASTIC CONTAINER versus SODIUM ACETATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: POTASSIUM CHLORIDE 0 22 IN DEXTROSE 5 IN PLASTIC CONTAINER versus SODIUM ACETATE.
POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% IN PLASTIC CONTAINER vs SODIUM ACETATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Potassium is the principal intracellular cation and is essential for maintaining cellular membrane potential, nerve impulse transmission, and muscle contraction. Dextrose provides calories and may prevent ketosis.
Sodium acetate provides sodium ions and acetate ions. Acetate is metabolized to bicarbonate, which acts as a buffer to correct metabolic acidosis.
Intravenous; typical adult dose is 10-20 mEq/hour, not exceeding 40 mEq/hour or 150 mEq/day, with continuous cardiac monitoring and serum potassium monitoring.
Intravenous: 50-200 mL of 0.1-0.4 mEq/mL solution per dose; administer at a rate not exceeding 1 mEq/kg/hour; frequency based on serum bicarbonate and acid-base status.
None Documented
None Documented
The elimination half-life of potassium is not applicable in the traditional sense because potassium is an endogenous ion under tight homeostatic control. After intravenous infusion of a potassium load, the plasma concentration declines with a distribution phase of about 1-2 hours, followed by a slower elimination phase reflecting cellular uptake and renal excretion, with a terminal half-life of approximately 6-8 hours in patients with normal renal function.
2-3 minutes (rapid conversion to bicarbonate in circulation). Clinical context: Exogenous acetate (e.g., in parenteral nutrition) is quickly cleared, limiting duration of alkalinizing effect.
Renal: >90% of potassium intake is excreted by the kidneys, primarily via distal tubular secretion; fecal: <10%; minor sweat losses. In this formulation (KCl 0.22% in D5W), the potassium content is 2 mEq per 100 mL (approximately 20 mEq/L).
Primarily renal; acetate is rapidly metabolized to bicarbonate via the Krebs cycle, with less than 5% excreted unchanged in urine.
Category C
Category C
Electrolyte Supplement
Electrolyte Supplement